Your team

Meet the Resurfacing Comparison Team

The Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital is staffed by four consultants working inside a tertiary general hospital. Ke He, MD, is responsible for the medical review of this site and assesses which resurfacing route a given skin can tolerate. A comparison of this kind also involves the other three: the surgical view of a scar that resurfacing cannot reach, the assessment of a complaint that is really loose skin rather than surface quality, and the dermatological control of pigment and barrier disease that has to come first.

Specialist profiles

Who reviews this content

Ke He (何锞)

Deputy Director & Head of Skin & Laser Aesthetics · Attending Physician, Licensed Aesthetic Attending · Lead Physician of This Site

Skin and laser aesthetics · resurfacing and scarring · pigment risk assessment

Dr. Ke He is Deputy Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital and head of its skin and laser aesthetic service — and she is the lead physician of this site. A core specialist formerly at the Plastic and Aesthetic Surgery Department of Xinqiao Hospital, affiliated with Army Medical University, she has worked on the clinical front line in skin laser and injectable aesthetics for more than 20 years, serving over ten thousand patients.

Both routes in this comparison arrive at the same consultation, and Dr. He treats them as answers to different findings rather than as versions of one treatment. Her part of the decision is the skin rather than the lesion: how the surrounding skin has behaved after previous injuries, how much pigment it produces when it is inflamed, how much oil it makes, and how long a period of open healing the patient can actually protect. Where a test area is warranted she will treat a small patch first and judge the response before committing the face to it, and she regards an assessment that ends in a smaller plan than the patient expected as one that worked.

Clinical focus

Assessment of scarring, texture and pigment before a resurfacing plan is made
Skin-type and pigment-risk assessment, including test-area treatment
Non-ablative and ablative resurfacing, and the honest limits of each
Aftercare of skin healing from an ablative treatment
Management of a result that is slower to settle than expected

Academic roles & achievements

Member, Laser Medicine Group, Chinese Medical Association Plastic Surgery Branch
Member, Facial Rejuvenation Group, Chinese Medical Association Plastic Surgery Branch
Member, Chongqing Plastic Surgery Quality Control Center
Published 5 papers, holds 5 national patents, and introduced 2 new clinical techniques

Two routes, two sets of terms

One route asks your skin to grow a new surface and the other asks it to repair underneath the old one. Neither request is lighter than the other, and which one your skin can answer is an examination finding rather than a preference.

Shaoliang Wang (王韶亮)

Director, Plastic Surgery & Aesthetics Medical Center · Vice Chief Physician, Associate Professor, Doctor of Medicine

Plastic surgery · complex cases · scar revision

Dr. Shaoliang Wang is Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team he provides the surgical perspective and the tertiary-hospital backstop — the assessment when an operation is the honest answer, and the hospital-level care for the rare complication that needs it.

On this site Dr. Wang is the second opinion for a scar that has not responded to a resurfacing course, and for the patient whose real complaint is loose skin rather than surface quality.

Clinical focus

Center leadership and multidisciplinary case review
Surgical assessment when an operation is the honest answer to descent or excess skin
Hospital-based care for the rare complication that needs theatre-level management

Tongchun Mao (毛彤春)

Deputy Director & Head of Aesthetic Surgery · Vice Chief Physician, Licensed Aesthetic Attending

Aesthetic surgery · skin removal and repositioning

Dr. Tongchun Mao is an aesthetic surgeon within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is refinement and honest referral: he is the person who says so when an operation will do better than an injectable or a device.

His part of the decision is the one neither device answers: whether the change a patient wants is position or excess skin, which is an operation rather than a course of treatments.

Clinical focus

Aesthetic surgical assessment and refinement of contour and asymmetry
Honest referral when surgery outperforms a course of injections
Shared case planning within the four-physician team

Yongbo Jia (贾勇波)

Deputy Director & Head of Dermatology · Vice Chief Physician, Licensed Aesthetic Attending

Dermatology · pigment and barrier disease

Dr. Yongbo Jia is a dermatologist within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is medical skin assessment — diagnosing and managing pigment and barrier conditions, and treating skin that a device or an injection has irritated.

Melasma, active acne, rosacea and a damaged barrier are assessed and treated first at this hospital, because proceeding through them is how a resurfacing plan produces the result it was meant to avoid.

Clinical focus

Medical skin assessment behind injectable treatment plans
Diagnosis and management of pigment and barrier conditions
Dermatologic care of skin after irritation or a delayed reaction

The choice is made at an examination

Arrange an assessment. We will examine where your complaint sits in the skin, explain what each route can and cannot change for it, and say plainly when neither is the right answer.

Contact the Team